190 related articles for article (PubMed ID: 30765804)
1. Three distinct regions of cRaf kinase domain interact with membrane.
Prakash P; Hancock JF; Gorfe AA
Sci Rep; 2019 Feb; 9(1):2057. PubMed ID: 30765804
[TBL] [Abstract][Full Text] [Related]
2. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
3. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
[TBL] [Abstract][Full Text] [Related]
4. Active Ras induces heterodimerization of cRaf and BRaf.
Weber CK; Slupsky JR; Kalmes HA; Rapp UR
Cancer Res; 2001 May; 61(9):3595-8. PubMed ID: 11325826
[TBL] [Abstract][Full Text] [Related]
5. Structural snapshots of RAF kinase interactions.
Rezaei Adariani S; Buchholzer M; Akbarzadeh M; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
Biochem Soc Trans; 2018 Dec; 46(6):1393-1406. PubMed ID: 30381334
[TBL] [Abstract][Full Text] [Related]
6. Raf inhibitors target ras spatiotemporal dynamics.
Cho KJ; Kasai RS; Park JH; Chigurupati S; Heidorn SJ; van der Hoeven D; Plowman SJ; Kusumi A; Marais R; Hancock JF
Curr Biol; 2012 Jun; 22(11):945-55. PubMed ID: 22560614
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.
Cookis T; Mattos C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356620
[TBL] [Abstract][Full Text] [Related]
8. Analyses of the oncogenic BRAF
Cope NJ; Novak B; Liu Z; Cavallo M; Gunderwala AY; Connolly M; Wang Z
J Biol Chem; 2020 Feb; 295(8):2407-2420. PubMed ID: 31929109
[TBL] [Abstract][Full Text] [Related]
9. Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase.
Baljuls A; Mahr R; Schwarzenau I; Müller T; Polzien L; Hekman M; Rapp UR
J Biol Chem; 2011 May; 286(18):16491-503. PubMed ID: 21454547
[TBL] [Abstract][Full Text] [Related]
10. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
[TBL] [Abstract][Full Text] [Related]
11. The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF.
Yuan J; Ng WH; Yap J; Chia B; Huang X; Wang M; Hu J
J Biol Chem; 2018 Sep; 293(37):14276-14284. PubMed ID: 30030377
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.
Peng SB; Henry JR; Kaufman MD; Lu WP; Smith BD; Vogeti S; Rutkoski TJ; Wise S; Chun L; Zhang Y; Van Horn RD; Yin T; Zhang X; Yadav V; Chen SH; Gong X; Ma X; Webster Y; Buchanan S; Mochalkin I; Huber L; Kays L; Donoho GP; Walgren J; McCann D; Patel P; Conti I; Plowman GD; Starling JJ; Flynn DL
Cancer Cell; 2015 Sep; 28(3):384-98. PubMed ID: 26343583
[TBL] [Abstract][Full Text] [Related]
13. Activation kinetics of RAF protein in the ternary complex of RAF, RAS-GTP, and kinase on the plasma membrane of living cells: single-molecule imaging analysis.
Hibino K; Shibata T; Yanagida T; Sako Y
J Biol Chem; 2011 Oct; 286(42):36460-8. PubMed ID: 21862573
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic K-ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status.
Barceló C; Paco N; Beckett AJ; Alvarez-Moya B; Garrido E; Gelabert M; Tebar F; Jaumot M; Prior I; Agell N
J Cell Sci; 2013 Oct; 126(Pt 20):4553-9. PubMed ID: 23943869
[TBL] [Abstract][Full Text] [Related]
15. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.
Wang P; Laster K; Jia X; Dong Z; Liu K
Mol Cancer; 2023 Dec; 22(1):208. PubMed ID: 38111008
[TBL] [Abstract][Full Text] [Related]
16. Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.
Travers T; López CA; Agamasu C; Hettige JJ; Messing S; García AE; Stephen AG; Gnanakaran S
Biophys J; 2020 Aug; 119(3):525-538. PubMed ID: 32649863
[TBL] [Abstract][Full Text] [Related]
17. Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras.
Deora AA; Hajjar DP; Lander HM
Biochemistry; 2000 Aug; 39(32):9901-8. PubMed ID: 10933809
[TBL] [Abstract][Full Text] [Related]
18. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.
Mitra S; Ghosh B; Gayen N; Roy J; Mandal AK
J Biol Chem; 2016 Nov; 291(47):24579-24593. PubMed ID: 27703006
[TBL] [Abstract][Full Text] [Related]
19. MEK drives BRAF activation through allosteric control of KSR proteins.
Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
[TBL] [Abstract][Full Text] [Related]
20. Membrane localization, oligomerization, and phosphorylation are required for optimal raf activation.
Goetz CA; O'Neil JJ; Farrar MA
J Biol Chem; 2003 Dec; 278(51):51184-9. PubMed ID: 14530258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
